Factors Associated with In-stent Restenosis in Patients Following Percutaneous Coronary Intervention

Aim: to determine factors associated with In-Stent Restenosis (ISR) in patients following Percutaneous Coronary Intervention (PCI). Methods: a retrospective cross-sectional study was conducted using secondary information from medical records of post-PCI patients who underwent follow-up of angiograp...

Full description

Saved in:
Bibliographic Details
Main Authors: Dedi Wihanda, Idrus Alwi, Hamzah Shatri, E. Mudjaddid E. Mudjaddid
Format: Article
Language:English
Published: Interna Publishing 2015-07-01
Series:Acta Medica Indonesiana
Online Access:https://www.actamedindones.org/index.php/ijim/article/view/34
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849408897221132288
author Dedi Wihanda
Idrus Alwi
Hamzah Shatri
E. Mudjaddid E. Mudjaddid
author_facet Dedi Wihanda
Idrus Alwi
Hamzah Shatri
E. Mudjaddid E. Mudjaddid
author_sort Dedi Wihanda
collection DOAJ
description Aim: to determine factors associated with In-Stent Restenosis (ISR) in patients following Percutaneous Coronary Intervention (PCI). Methods: a retrospective cross-sectional study was conducted using secondary information from medical records of post-PCI patients who underwent follow-up of angiography PCI between January 2009 and March 2014 at The Integrated Cardiovascular Service Unit, Cipto Mangunkusumo Hospital, Jakarta. Angiographic ISR was defined when the diameter of stenosis ≥50% at follow-up angiography including the diameter inside the stent and diameter with five-mm protrusion out of the proximal and distal ends of the stent. Results: there were 289 subjects including 133 subjects with and 156 subjects without ISR. The incidence of ISR in patients using of bare-metal stent (BMS) and drug-eluting stent (DES) were 61.3% and 40.7%, respectively. Factors associated with ISR are stent-type (OR=4.83, 95% CI 2.51-9.30), stent length (OR=3.71, 95% CI 1.99-6.90), bifurcation lesions (OR=2.43, 95% CI 1.16-5.10), smoking (OR=2.30, 95% CI 1.33-3.99), vascular diameter (OR=2.18, 95% CI 1.2-3.73), hypertension (OR=2.16, 95% CI 1.16-4.04) and diabetes mellitus (OR=2.14, 95% CI 1.23-3.70). Conclusion: stent type, stent length, bifurcation lesions, smoking, vascular diameter, hypertension and DM are factors associated with ISR in patients following PCI. Key words: bare-metal stent; drug-eluting stent; in-stent restenosis.
format Article
id doaj-art-3e66b3b2162c4276980bb9cfa76fb78a
institution Kabale University
issn 0125-9326
2338-2732
language English
publishDate 2015-07-01
publisher Interna Publishing
record_format Article
series Acta Medica Indonesiana
spelling doaj-art-3e66b3b2162c4276980bb9cfa76fb78a2025-08-20T03:35:40ZengInterna PublishingActa Medica Indonesiana0125-93262338-27322015-07-0147334Factors Associated with In-stent Restenosis in Patients Following Percutaneous Coronary InterventionDedi Wihanda0Idrus Alwi1Hamzah Shatri2E. Mudjaddid E. Mudjaddid3Department of Internal Medicine, Faculty of Medicine Universitas Indonesia - Cipto Mangunkusumo Hospital, Jakarta, IndonesiaDepartment of Internal Medicine, Faculty of Medicine Universitas Indonesia - Cipto Mangunkusumo Hospital, Jakarta, IndonesiaDepartment of Internal Medicine, Faculty of Medicine Universitas Indonesia - Cipto Mangunkusumo Hospital, Jakarta, IndonesiaDepartment of Internal Medicine, Faculty of Medicine Universitas Indonesia - Cipto Mangunkusumo Hospital, Jakarta, Indonesia Aim: to determine factors associated with In-Stent Restenosis (ISR) in patients following Percutaneous Coronary Intervention (PCI). Methods: a retrospective cross-sectional study was conducted using secondary information from medical records of post-PCI patients who underwent follow-up of angiography PCI between January 2009 and March 2014 at The Integrated Cardiovascular Service Unit, Cipto Mangunkusumo Hospital, Jakarta. Angiographic ISR was defined when the diameter of stenosis ≥50% at follow-up angiography including the diameter inside the stent and diameter with five-mm protrusion out of the proximal and distal ends of the stent. Results: there were 289 subjects including 133 subjects with and 156 subjects without ISR. The incidence of ISR in patients using of bare-metal stent (BMS) and drug-eluting stent (DES) were 61.3% and 40.7%, respectively. Factors associated with ISR are stent-type (OR=4.83, 95% CI 2.51-9.30), stent length (OR=3.71, 95% CI 1.99-6.90), bifurcation lesions (OR=2.43, 95% CI 1.16-5.10), smoking (OR=2.30, 95% CI 1.33-3.99), vascular diameter (OR=2.18, 95% CI 1.2-3.73), hypertension (OR=2.16, 95% CI 1.16-4.04) and diabetes mellitus (OR=2.14, 95% CI 1.23-3.70). Conclusion: stent type, stent length, bifurcation lesions, smoking, vascular diameter, hypertension and DM are factors associated with ISR in patients following PCI. Key words: bare-metal stent; drug-eluting stent; in-stent restenosis. https://www.actamedindones.org/index.php/ijim/article/view/34
spellingShingle Dedi Wihanda
Idrus Alwi
Hamzah Shatri
E. Mudjaddid E. Mudjaddid
Factors Associated with In-stent Restenosis in Patients Following Percutaneous Coronary Intervention
Acta Medica Indonesiana
title Factors Associated with In-stent Restenosis in Patients Following Percutaneous Coronary Intervention
title_full Factors Associated with In-stent Restenosis in Patients Following Percutaneous Coronary Intervention
title_fullStr Factors Associated with In-stent Restenosis in Patients Following Percutaneous Coronary Intervention
title_full_unstemmed Factors Associated with In-stent Restenosis in Patients Following Percutaneous Coronary Intervention
title_short Factors Associated with In-stent Restenosis in Patients Following Percutaneous Coronary Intervention
title_sort factors associated with in stent restenosis in patients following percutaneous coronary intervention
url https://www.actamedindones.org/index.php/ijim/article/view/34
work_keys_str_mv AT dediwihanda factorsassociatedwithinstentrestenosisinpatientsfollowingpercutaneouscoronaryintervention
AT idrusalwi factorsassociatedwithinstentrestenosisinpatientsfollowingpercutaneouscoronaryintervention
AT hamzahshatri factorsassociatedwithinstentrestenosisinpatientsfollowingpercutaneouscoronaryintervention
AT emudjaddidemudjaddid factorsassociatedwithinstentrestenosisinpatientsfollowingpercutaneouscoronaryintervention